Skip to main content
NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.440
-0.090 (-5.88%)
Feb 27, 2026, 4:00 PM EST - Market closed

NovaBay Pharmaceuticals Revenue

NovaBay Pharmaceuticals had revenue of $521.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $10.30M, up 390.34% year-over-year. In the year 2024, NovaBay Pharmaceuticals had annual revenue of $9.78M, down -6.45%.

Revenue (ttm)
$10.30M
Revenue Growth
+390.34%
P/S Ratio
3.65
Revenue / Employee
$735,857
Employees
14
Market Cap
37.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.78M-674.00K-6.45%
Dec 31, 202310.46M-3.95M-27.42%
Dec 31, 202214.40M4.20M41.16%
Dec 31, 202110.20M270.00K2.72%
Dec 31, 20209.93M3.34M50.54%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xilio Therapeutics 31.80M
Veru Inc. 16.89M
Palatin Technologies 8.96M
CervoMed 6.16M
Aligos Therapeutics 2.65M
Lisata Therapeutics 1.07M
Revenue Rankings

NBY News

More News